Company
Cytuvax
- Biotech
- Headquarters:
- Maastricht
Description
Cytuvax develops therapeutic cancer vaccines and prophylactic vaccines against viral and bacterial pathogens using a depot-attached cytokine adjuvant platform for clinical and preclinical applications with healthcare providers and researchers.